GLORY HEALTH (Stock Code: 02329) announced its monthly return for February 2026. Authorized share capital stood at 10.00 million Hong Kong dollars, with a par value of HKD 0.001 per share and no changes recorded during the reporting period.

Total issued shares remained at 4.44 billion, with zero treasury shares. The company confirmed compliance with the minimum 15% public float requirement as prescribed at the time of listing. No movements were reported in share options, warrants, convertibles, or any other share-related agreements.